Integra LifeSciences Holdings Corporation (IART) Financials

$22.71

south_east
-$0.11 (-0.48%)
Day's range
$22.3
Day's range
$23.16

IART Income statement / Annual

Last year (2024), Integra LifeSciences Holdings Corporation's total revenue was $1.61 B, an increase of 4.47% from the previous year. In 2024, Integra LifeSciences Holdings Corporation's net income was -$6.94 M. See Integra LifeSciences Holdings Corporation,s key income statements, including revenue, expenses, profit, and income.

Period FY-2024 FY-2023 FY-2022 FY-2021 FY-2020 FY-2019 FY-2018 FY-2017 FY-2016 FY-2015
Period Ended 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015
Operating Revenue $1.61 B $1.54 B $1.56 B $1.54 B $1.37 B $1.52 B $1.47 B $1.19 B $992.08 M $882.73 M
Cost of Revenue $728.47 M $653.18 M $587.36 M $597.81 M $520.83 M $564.68 M $571.50 M $435.51 M $349.09 M $326.54 M
Gross Profit $882.06 M $888.39 M $970.31 M $944.64 M $851.03 M $952.88 M $900.95 M $752.73 M $642.99 M $556.19 M
Gross Profit Ratio 0.55 0.58 0.62 0.61 0.62 0.63 0.61 0.63 0.65 0.63
Research and Development Expenses $115.38 M $174.59 M $101.19 M $93.05 M $77.38 M $79.57 M $78.04 M $63.46 M $58.16 M $50.90 M
General & Administrative Expenses $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $690.75 M $624.10 M $455.63 M $415.76 M
Selling & Marketing Expenses $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Selling, General & Administrative Expenses $716.98 M $592.64 M $616.32 M $637.45 M $594.53 M $687.60 M $690.75 M $624.10 M $455.63 M $415.76 M
Other Expenses $21.29 M $69.16 M $13.88 M $16.91 M $27.76 M $27.03 M $8.29 M $1.35 M $845,000.00 $4.59 M
Operating Expenses $853.65 M $836.39 M $731.39 M $747.41 M $699.66 M $794.20 M $789.95 M $707.92 M $527.65 M $476.61 M
Cost And Expenses $1.58 B $1.43 B $1.32 B $1.35 B $1.22 B $1.36 B $1.36 B $1.14 B $876.74 M $803.15 M
Interest Income $20.04 M $17.20 M $11.92 M $6.74 M $9.30 M $10.78 M $2.80 M $255,000.00 $24,000.00 $13,000.00
Interest Expense $70.63 M $51.38 M $49.59 M $50.40 M $71.58 M $53.96 M $64.68 M $35.02 M $25.80 M $23.52 M
Depreciation & Amortization $140.89 M $123.51 M $121.12 M $123.67 M $118.99 M $114.70 M $115.70 M $88.90 M $72.67 M $9.95 M
EBITDA $193.29 M $274.01 M $391.10 M $366.33 M $267.93 M $231.03 M $241.04 M $135.23 M $231.73 M $195.59 M
EBITDA Ratio 0.12 0.18 0.18 0.16 0.14 0.14 0.1 0.06 0.13 0.11
Operating Income Ratio 0.02 0.07 0.15 0.13 0.11 0.12 0.08 0.04 0.12 0.09
Total Other Income/Expenses Net -$46.65 M -$30.46 M -$25.03 M $17.45 M -$57.85 M -$33.66 M -$53.60 M -$33.42 M -$24.93 M -$18.92 M
Income Before Tax -$18.24 M $81.07 M $213.89 M $214.68 M $93.52 M $60.10 M $57.40 M $11.39 M $90.41 M $60.67 M
Income Before Tax Ratio -0.01 0.05 0.14 0.14 0.07 0.04 0.04 0.01 0.09 0.07
Income Tax Expense -$11.29 M $13.33 M $33.34 M $45.60 M -$40.37 M $9.90 M -$3.40 M -$53.36 M $15.84 M $53.82 M
Net Income -$6.94 M $67.74 M $180.55 M $169.08 M $133.89 M $50.20 M $60.80 M $64.74 M $74.56 M -$3.52 M
Net Income Ratio -0 0.04 0.12 0.11 0.1 0.03 0.04 0.05 0.08 -0
EPS -0.0902 0.87 2.18 2 1.58 0.59 0.73 0.83 1 -0.0476
EPS Diluted -0.0902 0.84 2.16 1.98 1.57 0.58 0.72 0.82 0.94 -0.0476
Weighted Average Shares Out $77.01 M $78.17 M $83.00 M $84.70 M $84.65 M $85.64 M $82.86 M $78.39 M $74.72 M $73.88 M
Weighted Average Shares Out Diluted $77.01 M $80.34 M $83.52 M $85.49 M $85.23 M $86.49 M $84.45 M $79.12 M $79.19 M $73.88 M
Link